help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christie, R.
Right arrow Articles by Hyman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christie, R.
Right arrow Articles by Hyman, B.
(American Journal of Pathology. 2001;158:1065-1071.)
© 2001 American Society for Investigative Pathology


Regular Articles

Structural and Functional Disruption of Vascular Smooth Muscle Cells in a Transgenic Mouse Model of Amyloid Angiopathy

Richard Christie*, Masaru Yamada{dagger}, Michael Moskowitz*{dagger} and Bradley Hyman*

From the Departments of Neurology*
and Neurosurgery,{dagger}
Massachusetts General Hospital, Charlestown, Massachusetts

The deposition of amyloid Aß peptide in the wall of cerebral vessels (cerebral amyloid angiopathy), can lead to weakness and rupture of the vessel wall, resulting in hemorrhagic stroke. The Tg2576 transgenic mouse line, overexpressing mutant amyloid precursor protein in an age-dependent manner, forms amyloid angiopathy morphologically similar to that seen in the human. We report here the structural and functional disruption of smooth muscle cells (SMCs) in the walls of pial vessels affected by amyloid deposition in the Tg2576 mouse. We demonstrate, using multiphoton imaging, that the arrangement of SMCs becomes disorganized before the onset of cell death, and that these disorganized SMCs are unable to respond appropriately to application of endothelial-dependent and endothelial-independent vasodilators in a closed-cranial window preparation.





This article has been cited by other articles:


Home page
BrainHome page
N.-W. Hu, I. M. Smith, D. M. Walsh, and M. J. Rowan
Soluble amyloid-{beta} peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo
Brain, August 4, 2008; (2008) awn174v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Schroeter, K. Khan, R. Barbour, M. Doan, M. Chen, T. Guido, D. Gill, G. Basi, D. Schenk, P. Seubert, et al.
Immunotherapy Reduces Vascular Amyloid-{beta} in PDAPP Mice
J. Neurosci., July 2, 2008; 28(27): 6787 - 6793.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy
Brain, September 1, 2007; 130(9): 2310 - 2319.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. Hachinski, C. Iadecola, R. C. Petersen, M. M. Breteler, D. L. Nyenhuis, S. E. Black, W. J. Powers, C. DeCarli, J. G. Merino, R. N. Kalaria, et al.
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
Stroke, September 1, 2006; 37(9): 2220 - 2241.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
J. Neurosci., May 10, 2006; 26(19): 5167 - 5179.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. M. Robbins, R. A. Betensky, S. B. Domnitz, S. M. Purcell, M. Garcia-Alloza, C. Greenberg, G. W. Rebeck, B. T. Hyman, S. M. Greenberg, M. P. Frosch, et al.
Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease
J. Neurosci., January 11, 2006; 26(2): 365 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel
Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease
J. Neurosci., November 30, 2005; 25(48): 11165 - 11174.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
Amyloid Precursor Protein (APP) E693Q Transgenic Mice (APPDutch Mice)
Sci. Aging Knowl. Environ., October 27, 2004; 2004(43): tg5 - tg5.
[Full Text]


Home page
J. Neurosci.Home page
T. Mueggler, D. Baumann, M. Rausch, M. Staufenbiel, and M. Rudin
Age-Dependent Impairment of Somatosensory Response in the Amyloid Precursor Protein 23 Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., September 10, 2003; 23(23): 8231 - 8236.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. SHIN, H. S. CHO, G. W. REBECK, and S. M. GREENBERG
Vascular Changes in Iowa-Type Hereditary Cerebral Amyloid Angiopathy
Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Mueggler, C. Sturchler-Pierrat, D. Baumann, M. Rausch, M. Staufenbiel, and M. Rudin
Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice
J. Neurosci., August 15, 2002; 22(16): 7218 - 7224.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.